Teknoscienza 17 bibliografi a PhD, MSc, DDS; Leandro Chambrone, PhD, MSc, DDS, Claudio Mendes Pannuti, PhD, MSc, DDS, “Systematic Re- view Effi cacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol” JADA 2019:150(12):1015-1026 https://www.researchgate.netpublication/337440953_Ef- fi cacy_of_preprocedural_mouthrinses_in_the_reduction_ of_ microorganisms_in_aerosol_A_systematic_review R Izzetti, M Nisi, M Gabriele, F Graziani, “COVID-19 Trans- mission in Dental Practice: Brief Review of Preventive Mea- sures in Italy”, Review J Dent Res. 2020 Aug;99(9):1030-1038 https://pubmed.ncbi.nlm.nih.gov/32302257/ Daniel L. Popkin, Sarah Zilka, Matthew Dimaano, Hisa- shi Fujioka, Cristina Rackley, RobertSalata, Alexis Griffi th, Pranab K. Mukherjee, Mahmoud A. Ghannoum, Frank Es- per, « Cetylpyridinium Chloride (CPC) Exhibits Potent, Ra- pid Activity Against Infl uenza Viruses in vitro and in vivo, Pathogens and Immunity » 2017;2(2):252-269 https://pub- med.ncbi.nlm.nih.gov/28936484/ Dental Tribune Italian Edition - Giugno 2021 bibliografi a 1. 2. 3. O’Donnell VB, Thomas D, Stanton R, e ass. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS- CoV-2 Infection. Function 2020; 1.10.1093/function/zqaa002 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239187/ pdf/zqaa002.pdf Questo studio non è ancora stato riveduto o pubblicato in una testate scientifi ca, ma è disponibile in prestampa su un server di medicina. Seneviratne Chaminda J., Sim Xiang Ying J. e ass. “Effi cacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized Control Trial in Singapore” medRxiv preprint ; September 18, 2020. https://www.med- rxiv.org/content/10.1101/2020.09.14.20186494v1 Evelina Statkute, Richard Stanton e ass. ”Brief Report: The Virucidal Effi cacy of Oral Rinse Components Against SARS- CoV-2 In Vitro” bioRxiv preprint, November 13, https:// www.biorxiv.org/content/10.1101/2020.11.13.381079v1.full. pdf 4. 5. 6. 7. Popkin DL, Zikka S, Dimaano M, e ass., “Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against In- fl uenza Viruses in vitro and in vivo”, Pathog. Immun., 2017 (2) 252-269 https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC5605151/pdf/pai-2-253.pdf Xu Hao, Zhong Liang e ass. “High expression of ACE2 re- ceptor of 2019-nCoV on the epithelial cells of oral mucosa” International Journal of Oral Science, 24 Feb 2020. https:// www.nature.com/articles/s41368-020-0074-x Daniel H. Fine, Carlos Mendieta, Michael L. Barnett,f Da- vid Furgang, Ronnie Meyers, Arnold Olshan,f and Jack Vin- cent, Effi cacy of Preprocedural Rinsing With an Antiseptic in Reducing Viable Bacteria in Dental Aerosols, Journal of Periodontology, Vol 63, Issue 10, October 1992 https://aap. onlinelibrary.wiley.com/doi/abs/10.1902/jop.1992.63.10.821 Vanessa Costa Marui, DDS; Maria Luisa Silveira Souto, DDS; Emanuel Silva Rovai, DDS, Giuseppe Alexandre Romito, 8. 9. DOPPIA AZIONE ANTISETTICA Formulazione con Clorexidina e CPC, per una maggior protezione EFFICACIA DIMOSTRATA CLINICAMENTE 3. 2. Virucidal activity of oral care pro- ducts against SARS-CoV-2 in vitro 1. World Health Organization, WHO Corona- virus Disease (COVID-19) Dashboard, htt- ps://covid19.who.int/ [Accessed 18 November 2020]. Zhu N, Zhang D, Wang W, Li X, Yang B, M S, et al. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med 2020;382:727–33. Herrera D, Serrano J, Roldán S, Sanz M. Is the oral cavity relevant in SARS-CoV-2 pan- demic? Clin Oral Investig 2020;24:2925–30. Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev 2013;77:144–56. Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jen- kins TM, et al. Povidone-iodine demonstra- tes rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. Infect Dis Ther 2020;9:669–75. Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Comparison of in vit- ro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses. J Prothodont 2020;29:599–603. 4. 5. 6. 7. Meister TL, Brüggemann Y, Todt D, Conzel- mann C, Muller JA, Grob R, et al. Virucidal effi cacy of different oral rinses against sever acute respiratory syndrome coronavirus 2. J Infec Dis 2020;222:1289–92. 8. Martínez Lamas L, Diz Dios P, Pérez Ro- dríguez MT, Del Campo Pérez V, Cabrera Alvargonzalez JJ, López Domínguez AM, et al. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis 2020, http://dx.doi.org/10.1111/odi.13526 [Epub ahead of print]. Gonzalo Garijo MA, Durán Quintana JA, Bobadilla González P, Máiquez Asuero P. Anaphylactic shock following povidone. Ann Pharmacother 1996;30:37–40. 9. 10. Ohtoshi T, Yamauchi N, Tadokoro K, Mi- yachi S, Suzuki S, Miyamoto T, et al. IgE antibody-mediated shock reaction caused by topical application of chlorhexidine. Clin Al- lergy 1986;16:155–61. 11. Centers for Disease Control and Prevention, Guidance for Dental Settings. https://www. cdc.gov/coronavirus/2019-ncov/hcp/dental- settings.html [Accessed 18 November 2020]. 12. American Dental Hygienists’ Association, ADHA Interim Guidance on Returning to Work, https://www.adha.org/resources- docs/ADHA TaskForceReport.pdf [Accessed 18 November 2020]. 14. 13. Yoon JG, Yoon JG, Song JY, Yoon SY, Lim CS, Seong H, et al. Clinical signifi cance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci 2020;35:e195. [14] Baker N, Williams AJ, Tropsha A, Ekins S. Repurposing quaternary ammonium compounds as potential treatments for CO- VID-19. Pharma Res 2020;37:104. [15] Buenaventura AV, Ruiz CC. Use of mouth- washes against COVID-19 in dentistry. Br J Oral Maxillofac Surg 2020;58:924–7. 15. 16. Meyers C, Robinson R, Milici J, Alam S, Quillen D, Goldenberg D, et al. Lowering the transmission and spread of human coronavi- rus. J Med Virol 2021;93:1605–12. 17. Green A, Roberts G, Tobery T, Vincent C, Ba- rili M, Jones C. In vitro assessment of the viru- cidal activity of four mouthwashes containing cetylpyridinium chloride, ethanol, zinc and a mix of enzyme and proteins against a hu- man coronavirus. bioRxiv 2020, http://dx.doi. org/10.1101/2020.10.28.359257 [preprint]. Seneviratne CJ, Balan P, Ki KKK, Udawatte NS, Lai D, Lin DNH, et al. Effi cacy of com- mercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized Control Trial in Singapore. Infection 2020, http://dx.doi. org/10.1007/s15010- [Epub ahead of print]. 020-01563-9 18. 19. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020;104:246–51. 20. Khokhar M, Roy D, Purohit P, Goyal M, Setia P. Viricidal treatments for prevention of coronavirus infection. Pathog Glob Health 2020;114:349–59. [21] Naganori N, Sato K, Yamagishi J, Tahara M, Nakatsu Y, Seki F, et al. Consensus and variations in cell lines specifi city among human metapneumovirus strains. PLoS One 2020;14:e0215822. 21. American Society for Testing and Materials, ASTM E1052-20 Standard Practice to Assess the Activity of Microbicides against Viruses in Suspension, https://www.astm.org/Stan- dards/E1052.htm. 22. Bonesvoll P, Gjermo P. A comparison bet- ween chlorhexidine and some quaternary ammonium compounds with regard to re- tention, salivary concentration and plaque- inhibiting effect in the human mouth after mouth rinses. Arch Oral Biol 1978;23:289–94 PER MAGGIORI INFO: SUNSTAR ITALIANA S.R.L. 800-580840 A D